Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves’ disease, and modulation by methimazole therapy - Antonelli, A; Rotondi, M; Fallahi, P; Romagnani, P; Ferrari, S M; Barani, L; Ferrannini, E; Serio, M (Clin Endocrinol (Oxf), 2006)